Sagient Research Products About Us Contact Us
Coverage Universe
  Drugs Covered: 3,119
  Catalysts Covered: 4,609
  Revenue Models: 467
  Companies Covered: 804
  Companies Evaluated:  33

>> Advanced Catalyst Search <<

>> Advanced Drug Search <<

>> Advanced Event Search <<

Search
Catalysts Drug Profiles
Impact Events Company Profiles
Target    Indication   
Sample Reports
Special Reports
07/10/08 Diabetes Update Following 2008 ADA and FDA Advisory Committee Meetings
06/17/08 2008 Post-ASCO Report
05/30/08 2008 Pre-ADA Report
05/15/08 2008 ASCO Abstract Summary
05/12/08 2008 Pre-ASCO Report
05/05/08 Bipolar Indication Report
02/01/08 2008 BioMedTracker Outlook
01/08/08 FDA Approval Study   More...
Date Report Title
07/10/08 Diabetes Update Following 2008 ADA and FDA Advisory Committee Meetings
06/17/08 2008 Post-ASCO Report
05/30/08 2008 Pre-ADA Report
05/15/08 2008 ASCO Abstract Summary
05/12/08 2008 Pre-ASCO Report
05/05/08 Bipolar Indication Report
02/01/08 2008 BioMedTracker Outlook
01/08/08 FDA Approval Study
12/18/07 2007 Post-ASH Report
12/12/07 Kuvan PDUFA Sensitivity Analysis
12/07/07 Multiple Sclerosis (MS) Indication Report
12/04/07 2007 Pre-ASH Report
11/09/07 BioMarin (BMRN) Valuation Update
10/30/07 2007 AASLD Preview
10/01/07 Salix (SLXP) Coverage Initiation
09/21/07 Catalyst Impact Study
09/21/07 Orexigen (OREX) Coverage Initiation
08/28/07 Schizophrenia Indication Report
07/27/07 HGSI Coverage Initiation
07/09/07 2007 Post-ADA Report
06/21/07 2007 Post-ASCO Report
06/15/07 InterMune Coverage Initiation
05/17/07 2007 Pre-ASCO Report
04/27/07 Spectrum Coverage Initiation
04/13/07 Idiopathic Pulmonary Fibrosis (IPF) Indication Report
03/30/07 2007 Post-ACC Report
03/13/07 HIV Indication Report - Update
03/01/07 CDAD Indication Report
02/23/07 Obesity Indication Report - Update
01/31/07 2007 BioMedTracker Outlook
01/19/07 5 and 10 Year Pipeline Updates
12/20/06 2006 Post-ASH Report
12/08/06 2006 Pre-ASH Report
12/01/06 Glioblastoma Multiforme (GBM) Indication Report
10/30/06 Hereditary Angioedema (HAE) Indication Report
10/20/06 Renovis Coverage Initiation
10/04/06 Coley Coverage Initiation
09/22/06 Hypercholesterolemia/ Dyslipidemia Indication Report
08/31/06 NSCLC Indication Report - Update
07/13/06 Type II Diabetes Indication Report - Update
07/12/06 Renal Cell Cancer Indication Report - Update
06/21/06 2006 Post-ASCO Report
06/20/06 Sepracor Coverage Initiation
06/16/06 2006 Post-ADA Report
05/30/06 2006 ASCO Preview
05/12/06 Insomnia Indication Report - Update
05/08/06 Spreading Agents Indication Report
05/04/06 Panacos Coverage Initiation
05/02/06 HIV Indication Report - Update
04/13/06 Arena Coverage Initiation
04/12/06 Resistant Hypertension Indication Report
03/28/06 Systemic Lupus Erythematosus (SLE) Indication Report
03/17/06 Asthma Indication Report
03/09/06 MannKind Coverage Initiation
03/01/06 Pharmion and GPC Biotech AG Coverage Initiation
02/08/06 HPV Vaccine Report
01/31/06 Cardiome Coverage Initiation
01/24/06 Obesity Indication Report
01/11/06 2006 BioMedTracker Outlook
12/22/05 COPD Indication Report
12/15/05 2005 Post-ASH Report
12/01/05 2005 ASH Catalyst Preview
11/08/05 Hepatitis C Indication Report
10/10/05 HIV/AIDS Indication Report
10/07/05 Alkermes Coverage Initiation
08/29/05 Nabi Coverage Initiation
08/25/05 ACS, CABG, and PCI Indication Report
08/15/05 Renal Cell Cancer Indication Report
07/21/05 Parkinson Disease Indication Report
07/20/05 Ligand Coverage Initiation
07/11/05 Celgene Coverage Initiation
06/29/05 2005 ADA Post-Conference Report
05/25/05 2005 Post ASCO Report
05/10/05 2005 ASCO Preview
05/09/05 Cubist Coverage Initiation
05/02/05 Skin and Skin-Structure Infections Indication Report
04/13/05 NPS Coverage Initiation
03/31/05 Incyte Corporation Coverage Initiation
03/28/05 NSCLC Indication Report
02/25/05 Ischemic Stroke Indication Report
02/11/05 Alzheimer's Disease Indication Report
01/27/05 Hypertension Indication Report
01/14/05 Myelodysplastic Syndrome Indication Report
01/13/05 Type II Diabetes Indication Report
01/06/05 2005 BioMedTracker Outlook
12/14/04 Insomnia Indication Report
12/10/04 Post-ASH Coverage 2004
12/07/04 Wet AMD Indication Report
12/02/04 Pre-ASH Coverage 2004
11/16/04 Multiple Sclerosis Indication Report
11/08/04 Osteoporosis Indication Report
 Questions? Email Customer Support Privacy Policy     Important Legal Disclosure 

Copyright © 2008 Sagient Research Systems, Inc.  All rights reserved.